ResMed's latest marketcap:
As of 08/02/2025, ResMed's market capitalization has reached $40.87 B. According to our data, ResMed is the 551th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 40.87 B |
| Revenue (ttm) | 5.15 B |
| Net Income (ttm) | 1.4 B |
| Shares Out | 146.39 M |
| EPS (ttm) | 9.51 |
| Forward PE | 25.60 |
| Ex-Dividend Date | 08/14/2025 |
| Earnings Date | 07/31/2025 |
ResMed's yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 08/02/2025 | $40.87 B | 21.95% | 551 |
| 12/31/2024 | $33.57 B | 32.68% | 576 |
| 12/29/2023 | $25.3 B | -17.01% | 718 |
| 12/30/2022 | $30.49 B | -19.68% | 553 |
| 12/31/2021 | $37.96 B | 23.23% | 519 |
| 12/31/2020 | $30.8 B | 38.24% | 571 |
| 12/31/2019 | $22.28 B | 37.32% | 639 |
| 12/31/2018 | $16.23 B | 35.02% | 705 |
| 12/29/2017 | $12.02 B | 37.39% | 1085 |
| 12/30/2016 | $8.75 B | 16.66% | 1151 |
Company Profile
About ResMed Inc.
ResMed Inc. is a global leader in developing, manufacturing, and distributing medical devices and cloud-based software solutions for healthcare markets. Founded in 1989 and headquartered in San Diego, California, the company serves sleep clinics, home healthcare providers, and hospitals through a network of distributors and direct sales.
Business Segments
- Sleep and Respiratory Care: Focuses on innovative solutions for respiratory disorders, including sleep apnea.
- Software as a Service (SaaS): Provides cloud-based healthcare management and monitoring tools.
Key Products & Solutions
- Diagnostic Devices: ApneaLink Air (portable diagnostic tool) and NightOwl (cloud-connected diagnostic device).
- Remote Monitoring: AirView (cloud-based patient monitoring) and myAir (personalized therapy management app).
- Compliance Solutions: U-Sleep (streamlines sleep programs) and Propeller (connectivity modules).
- Out-of-Hospital Software: Brightree (HME management), MatrixCare (senior living solutions), HEALTHCAREfirst (home health EHR), and MEDIFOX DAN (specialized software).
Market Reach
ResMed serves a diverse clientele, including sleep clinics, home healthcare dealers, and hospitals, ensuring better respiratory care and streamlined healthcare operations worldwide.
Frequently Asked Questions
-
What is ResMed's (RMD) current market cap?As of 08/02/2025, ResMed (including the parent company, if applicable) has an estimated market capitalization of $40.87 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does ResMed (RMD) rank globally by market cap?ResMed global market capitalization ranking is approximately 551 as of 08/02/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.